Osteoporosis Drugs Industry Forecasts - China Focus
- ASI3276371
- 93 Pages
- October 2019
- Pharmaceuticals
Although China has enjoyed the benefits of an expanding market for production and distribution, the industry is suffering from minimal innovation and investment in R&D and new product development. The sector’s economies of scale have yet to be achieved. Most domestic manufacturers lack the autonomic intellectual property and financial resources to develop their own brand name products.
This new study focuses on industry trends and forecasts with historical data (2008, 2013 and 2018) and long-term forecasts through 2023 and 2028 are presented.
The primary and secondary research is done in China in order to access up-to-date government regulations, market information and industry data. Data were collected from the Chinese government publications, Chinese language newspapers and magazines, industry associations, local governments’ industry bureaus, industry publications, and our in-house databases.
Asia Market Info & Dev Co. is one of the leading sources for up-to-date market information and research on the fastest-growing Chinese markets. We have published over 1,500 reports focusing on the Chinese markets, industry forecasts and company profiles. We provide hard-to-find market data and analyses. Our publications are intended to help international marketers identify business opportunities and promote their product sales in the Chinese markets.
I. INTRODUCTION
Report Scope and Methodology
Executive Summary
II. BUSINESS ENVIRONMENT
Economic Outlook
Key Economic Indicators
Industrial Output
Population and Labor
Foreign Investment
Foreign Trade
Financial and Tax Regulations
Banking System and Regulations
Foreign Exchange
Taxes, Tariff and Custom Duties
Market Trends
Technology Development
Market Development
Major Industry Development
Regional Development
Enterprise Development
Labor Market Development
IV. OSTEOPOROSIS DRUGS PRODUCTION AND DEMAND
Overview
Osteoporosis Drugs Production and Demand
Calcium Drugs
Supply and Demand
Major Manufacturers
Bisphosphonate Drugs
Supply and Demand
Major Manufacturers
Calcitonin Drugs
Supply and Demand
Major Manufacturers
Estrogen Drugs
Supply and Demand
Major Manufacturers
Osteoporosis Drugs Import and Export
LIST OF TABLES
I. INTRODUCTION
Economic Outlook Summary
II. BUSINESS ENVIRONMENT
Key Economic Indicators
Industrial Output
Population and Labor Force Trends
Foreign Investment and Loans
Foreign Trade
IV. OSTEOPOROSIS DRUGS PRODUCTION AND DEMAND
China's Osteoporosis Drugs Sales Volume and Market Share by Class
China's Major Calcium Drugs Market Share by Kind
China’s Major Calcium Drugs Manufacturers
China's Major Bisphosphonate Drugs Market Share by Kind
China’s Major Bisphosphonate Drugs Manufacturers
China's Major Calcitonin Drugs Market Share by Kind
China’s Major Calcitonin Drugs Manufacturers
China's Major Estrogen Drugs Market Share by Kind
China’s Major Estrogen Drugs Manufacturers
China’s Osteoporosis Drugs Import Volume by Country
China’s Osteoporosis Drugs Export Volume by Country
LIST OF CHARTS
I. INTRODUCTION
China’s Osteoporosis Drugs Sales Volume
China’s Major Class of Osteoporosis Drugs
II. BUSINESS ENVIRONMENT
China’s GDP and Growth Rate
Industrial Output by Ownership
China’s Imports and Exports
IV. OSTEOPOROSIS DRUGS PRODUCTION AND DEMAND
China’s Osteoporosis Drugs Sales Volume
China's Major Class of Osteoporosis
China's Osteoporosis Drugs Sales Volume and Market Share by Class
China’s Calcium Drugs Sales Volume
China's Major Calcium Drugs Market Share by Kind
China’s Bisphosphonate Drugs Sales Volume
China's Major Bisphosphonate Drugs Market Share by Kind
China’s Calcitonin Drugs Sales Volume
China's Major Calcitonin Drugs Market Share by Kind
China’s Estrogen Drugs Sales Volume
China's Major Estrogen Drugs Market Share by Kind
China’s Osteoporosis Drugs Import Volume
China’s Osteoporosis Drugs Import Volume by Country
China’s Osteoporosis Drugs Export Volume
China’s Osteoporosis Drugs Import and Export
China’s Osteoporosis Drugs Export Volume by Country
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
